Completing enrollment is typically one of the most critical milestones in a clinical trial. Enrollment delays impact the study budget, site resources, and downstream timelines. Therefore, it is important to identify potential risks to enrollment early in the study, even during the protocol development process if possible. Defining risk mitigation strategies and setting quality tolerance limits allows the study team to quickly identify when a strategy must be implemented to keep enrollment on track. In this webinar, we will discuss how we have used a risk-based quality management system to document enrollment risks and creative solutions we have implemented.
Executive Director, Project Delivery
A pain expert at Rho, Ms. Baggett has over 14 years of clinical trial experience. In the last…
Senior Director, Project Management
A true leader within the Project Management department at Rho for more than 15 years, Brandy Lind has…
Nancy Yovetich, Ph.D.
Principal Research Scientist
Dr. Nancy Yovetich is a Principal Research Scientist who has been involved in the research of psychiatric, neurologic…